nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic scleroderma	0.734	1	CiPCiCtD
Gemcitabine—TYMS—Methotrexate—systemic scleroderma	0.0489	0.355	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—systemic scleroderma	0.0403	0.293	CbGbCtD
Gemcitabine—ABCB1—Lisinopril—systemic scleroderma	0.0159	0.115	CbGbCtD
Gemcitabine—ABCB1—Captopril—systemic scleroderma	0.0119	0.0864	CbGbCtD
Gemcitabine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00937	0.0681	CbGbCtD
Gemcitabine—ABCB1—Prednisone—systemic scleroderma	0.00749	0.0544	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—systemic scleroderma	0.00376	0.0273	CbGbCtD
Gemcitabine—SLC28A1—digestive system—systemic scleroderma	0.00156	0.0528	CbGeAlD
Gemcitabine—POLD1—skin of body—systemic scleroderma	0.0013	0.044	CbGeAlD
Gemcitabine—CMPK1—connective tissue—systemic scleroderma	0.00115	0.0389	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—systemic scleroderma	0.00105	0.0356	CbGeAlD
Gemcitabine—POLD1—digestive system—systemic scleroderma	0.00104	0.0352	CbGeAlD
Gemcitabine—CMPK1—skin of body—systemic scleroderma	0.00103	0.0351	CbGeAlD
Gemcitabine—SLC28A3—digestive system—systemic scleroderma	0.000952	0.0323	CbGeAlD
Gemcitabine—CDA—tendon—systemic scleroderma	0.000886	0.03	CbGeAlD
Gemcitabine—POLD1—lung—systemic scleroderma	0.000867	0.0294	CbGeAlD
Gemcitabine—SLC29A2—tendon—systemic scleroderma	0.000828	0.0281	CbGeAlD
Gemcitabine—CMPK1—digestive system—systemic scleroderma	0.000828	0.0281	CbGeAlD
Gemcitabine—RRM2—skin of body—systemic scleroderma	0.000799	0.0271	CbGeAlD
Gemcitabine—SLC28A3—lung—systemic scleroderma	0.000795	0.0269	CbGeAlD
Gemcitabine—POLE—digestive system—systemic scleroderma	0.000776	0.0263	CbGeAlD
Gemcitabine—POLE—tendon—systemic scleroderma	0.000738	0.025	CbGeAlD
Gemcitabine—CMPK1—lung—systemic scleroderma	0.000691	0.0234	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—systemic scleroderma	0.000672	0.0228	CbGeAlD
Gemcitabine—TYMS—connective tissue—systemic scleroderma	0.000666	0.0226	CbGeAlD
Gemcitabine—RRM1—skin of body—systemic scleroderma	0.000663	0.0225	CbGeAlD
Gemcitabine—POLE—lung—systemic scleroderma	0.000648	0.022	CbGeAlD
Gemcitabine—RRM2—digestive system—systemic scleroderma	0.000639	0.0217	CbGeAlD
Gemcitabine—POLA1—tendon—systemic scleroderma	0.000636	0.0216	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—systemic scleroderma	0.000609	0.0207	CbGeAlD
Gemcitabine—RRM2—tendon—systemic scleroderma	0.000608	0.0206	CbGeAlD
Gemcitabine—TYMS—skin of body—systemic scleroderma	0.000602	0.0204	CbGeAlD
Gemcitabine—SLC29A1—connective tissue—systemic scleroderma	0.000597	0.0203	CbGeAlD
Gemcitabine—POLA1—lung—systemic scleroderma	0.000558	0.0189	CbGeAlD
Gemcitabine—RRM2—lung—systemic scleroderma	0.000534	0.0181	CbGeAlD
Gemcitabine—RRM1—digestive system—systemic scleroderma	0.000531	0.018	CbGeAlD
Gemcitabine—RRM1—tendon—systemic scleroderma	0.000505	0.0171	CbGeAlD
Gemcitabine—TYMS—digestive system—systemic scleroderma	0.000481	0.0163	CbGeAlD
Gemcitabine—TYMS—tendon—systemic scleroderma	0.000458	0.0155	CbGeAlD
Gemcitabine—RRM1—lung—systemic scleroderma	0.000443	0.015	CbGeAlD
Gemcitabine—SLC29A1—digestive system—systemic scleroderma	0.000432	0.0146	CbGeAlD
Gemcitabine—DCK—digestive system—systemic scleroderma	0.000412	0.014	CbGeAlD
Gemcitabine—SLC29A1—tendon—systemic scleroderma	0.000411	0.0139	CbGeAlD
Gemcitabine—TYMS—lung—systemic scleroderma	0.000402	0.0136	CbGeAlD
Gemcitabine—ABCC10—digestive system—systemic scleroderma	0.000393	0.0133	CbGeAlD
Gemcitabine—DCK—tendon—systemic scleroderma	0.000392	0.0133	CbGeAlD
Gemcitabine—ABCC10—tendon—systemic scleroderma	0.000374	0.0127	CbGeAlD
Gemcitabine—SLC29A1—lung—systemic scleroderma	0.00036	0.0122	CbGeAlD
Gemcitabine—DCK—lung—systemic scleroderma	0.000344	0.0117	CbGeAlD
Gemcitabine—ABCC10—lung—systemic scleroderma	0.000328	0.0111	CbGeAlD
Gemcitabine—ABCB1—blood vessel—systemic scleroderma	0.000306	0.0104	CbGeAlD
Gemcitabine—POLD1—Danazol—Prednisone—systemic scleroderma	0.000245	0.136	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Mometasone—systemic scleroderma	0.000156	0.0865	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Mometasone—systemic scleroderma	0.000151	0.084	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.000126	0.0702	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.000125	0.0693	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.000123	0.0686	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00012	0.0669	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.000114	0.0632	CbGdCrCtD
Gemcitabine—ABCB1—digestive system—systemic scleroderma	0.000113	0.00384	CbGeAlD
Gemcitabine—TYMS—Budesonide—Mometasone—systemic scleroderma	9.97e-05	0.0554	CbGdCrCtD
Gemcitabine—ABCB1—lung—systemic scleroderma	9.47e-05	0.00321	CbGeAlD
Gemcitabine—DCK—Desoximetasone—Prednisone—systemic scleroderma	8.48e-05	0.0472	CbGdCrCtD
Gemcitabine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	8.4e-05	0.000869	CcSEcCtD
Gemcitabine—Skin disorder—Mycophenolic acid—systemic scleroderma	8.34e-05	0.000862	CcSEcCtD
Gemcitabine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	8.3e-05	0.000858	CcSEcCtD
Gemcitabine—Cough—Lisinopril—systemic scleroderma	8.26e-05	0.000855	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	8.24e-05	0.000852	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisone—systemic scleroderma	8.23e-05	0.0458	CbGdCrCtD
Gemcitabine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	8.22e-05	0.000851	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	8.2e-05	0.000848	CcSEcCtD
Gemcitabine—Anorexia—Mycophenolic acid—systemic scleroderma	8.18e-05	0.000846	CcSEcCtD
Gemcitabine—Insomnia—Leflunomide—systemic scleroderma	8.14e-05	0.000842	CcSEcCtD
Gemcitabine—Paraesthesia—Leflunomide—systemic scleroderma	8.08e-05	0.000836	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	8.06e-05	0.000834	CcSEcCtD
Gemcitabine—Chest pain—Lisinopril—systemic scleroderma	8.06e-05	0.000834	CcSEcCtD
Gemcitabine—Arthralgia—Lisinopril—systemic scleroderma	8.06e-05	0.000834	CcSEcCtD
Gemcitabine—Myalgia—Lisinopril—systemic scleroderma	8.06e-05	0.000834	CcSEcCtD
Gemcitabine—Back pain—Mycophenolate mofetil—systemic scleroderma	8.03e-05	0.00083	CcSEcCtD
Gemcitabine—Dyspnoea—Leflunomide—systemic scleroderma	8.02e-05	0.00083	CcSEcCtD
Gemcitabine—Hypotension—Mycophenolic acid—systemic scleroderma	8.02e-05	0.000829	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	8.01e-05	0.000828	CcSEcCtD
Gemcitabine—Discomfort—Lisinopril—systemic scleroderma	7.97e-05	0.000824	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Methotrexate—systemic scleroderma	7.97e-05	0.000824	CcSEcCtD
Gemcitabine—Vomiting—Mometasone—systemic scleroderma	7.9e-05	0.000817	CcSEcCtD
Gemcitabine—Feeling abnormal—Azathioprine—systemic scleroderma	7.85e-05	0.000812	CcSEcCtD
Gemcitabine—Rash—Mometasone—systemic scleroderma	7.84e-05	0.00081	CcSEcCtD
Gemcitabine—Asthenia—Captopril—systemic scleroderma	7.83e-05	0.00081	CcSEcCtD
Gemcitabine—Dermatitis—Mometasone—systemic scleroderma	7.83e-05	0.00081	CcSEcCtD
Gemcitabine—Decreased appetite—Leflunomide—systemic scleroderma	7.82e-05	0.000809	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	7.82e-05	0.000809	CcSEcCtD
Gemcitabine—Headache—Mometasone—systemic scleroderma	7.78e-05	0.000805	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	7.77e-05	0.000803	CcSEcCtD
Gemcitabine—Insomnia—Mycophenolic acid—systemic scleroderma	7.76e-05	0.000803	CcSEcCtD
Gemcitabine—Fatigue—Leflunomide—systemic scleroderma	7.76e-05	0.000802	CcSEcCtD
Gemcitabine—Oedema—Lisinopril—systemic scleroderma	7.73e-05	0.0008	CcSEcCtD
Gemcitabine—Anaphylactic shock—Lisinopril—systemic scleroderma	7.73e-05	0.0008	CcSEcCtD
Gemcitabine—Pruritus—Captopril—systemic scleroderma	7.72e-05	0.000799	CcSEcCtD
Gemcitabine—Paraesthesia—Mycophenolic acid—systemic scleroderma	7.71e-05	0.000797	CcSEcCtD
Gemcitabine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	7.7e-05	0.000796	CcSEcCtD
Gemcitabine—Pain—Leflunomide—systemic scleroderma	7.69e-05	0.000796	CcSEcCtD
Gemcitabine—Constipation—Leflunomide—systemic scleroderma	7.69e-05	0.000796	CcSEcCtD
Gemcitabine—Infection—Lisinopril—systemic scleroderma	7.68e-05	0.000794	CcSEcCtD
Gemcitabine—Anaemia—Mycophenolate mofetil—systemic scleroderma	7.67e-05	0.000793	CcSEcCtD
Gemcitabine—Dyspnoea—Mycophenolic acid—systemic scleroderma	7.65e-05	0.000791	CcSEcCtD
Gemcitabine—Somnolence—Mycophenolic acid—systemic scleroderma	7.63e-05	0.000789	CcSEcCtD
Gemcitabine—Thrombocytopenia—Lisinopril—systemic scleroderma	7.57e-05	0.000783	CcSEcCtD
Gemcitabine—Neutropenia—Prednisone—systemic scleroderma	7.55e-05	0.000781	CcSEcCtD
Gemcitabine—Body temperature increased—Azathioprine—systemic scleroderma	7.53e-05	0.000779	CcSEcCtD
Gemcitabine—Skin disorder—Lisinopril—systemic scleroderma	7.51e-05	0.000777	CcSEcCtD
Gemcitabine—Malaise—Mycophenolate mofetil—systemic scleroderma	7.48e-05	0.000774	CcSEcCtD
Gemcitabine—Hyperhidrosis—Lisinopril—systemic scleroderma	7.47e-05	0.000773	CcSEcCtD
Gemcitabine—Diarrhoea—Captopril—systemic scleroderma	7.47e-05	0.000772	CcSEcCtD
Gemcitabine—Decreased appetite—Mycophenolic acid—systemic scleroderma	7.46e-05	0.000772	CcSEcCtD
Gemcitabine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	7.43e-05	0.000768	CcSEcCtD
Gemcitabine—Feeling abnormal—Leflunomide—systemic scleroderma	7.41e-05	0.000767	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	7.41e-05	0.000766	CcSEcCtD
Gemcitabine—Fatigue—Mycophenolic acid—systemic scleroderma	7.4e-05	0.000765	CcSEcCtD
Gemcitabine—Nausea—Mometasone—systemic scleroderma	7.38e-05	0.000764	CcSEcCtD
Gemcitabine—Anorexia—Lisinopril—systemic scleroderma	7.37e-05	0.000762	CcSEcCtD
Gemcitabine—Pain—Mycophenolic acid—systemic scleroderma	7.34e-05	0.000759	CcSEcCtD
Gemcitabine—Constipation—Mycophenolic acid—systemic scleroderma	7.34e-05	0.000759	CcSEcCtD
Gemcitabine—Hyperglycaemia—Prednisone—systemic scleroderma	7.28e-05	0.000753	CcSEcCtD
Gemcitabine—Cough—Mycophenolate mofetil—systemic scleroderma	7.24e-05	0.000749	CcSEcCtD
Gemcitabine—Hypotension—Lisinopril—systemic scleroderma	7.22e-05	0.000747	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—systemic scleroderma	7.21e-05	0.000745	CcSEcCtD
Gemcitabine—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.16e-05	0.000741	CcSEcCtD
Gemcitabine—Body temperature increased—Leflunomide—systemic scleroderma	7.11e-05	0.000736	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Prednisone—systemic scleroderma	7.1e-05	0.000734	CcSEcCtD
Gemcitabine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.07e-05	0.000731	CcSEcCtD
Gemcitabine—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000731	CcSEcCtD
Gemcitabine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000731	CcSEcCtD
Gemcitabine—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000731	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Prednisone—systemic scleroderma	7.06e-05	0.00073	CcSEcCtD
Gemcitabine—Myocardial infarction—Prednisone—systemic scleroderma	7.06e-05	0.00073	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.04e-05	0.000728	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	7.03e-05	0.000727	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	7.02e-05	0.000726	CcSEcCtD
Gemcitabine—Insomnia—Lisinopril—systemic scleroderma	6.99e-05	0.000723	CcSEcCtD
Gemcitabine—Discomfort—Mycophenolate mofetil—systemic scleroderma	6.98e-05	0.000722	CcSEcCtD
Gemcitabine—Paraesthesia—Lisinopril—systemic scleroderma	6.94e-05	0.000718	CcSEcCtD
Gemcitabine—Vomiting—Captopril—systemic scleroderma	6.94e-05	0.000718	CcSEcCtD
Gemcitabine—Dyspnoea—Lisinopril—systemic scleroderma	6.89e-05	0.000713	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	6.88e-05	0.0383	CbGdCrCtD
Gemcitabine—Rash—Captopril—systemic scleroderma	6.88e-05	0.000712	CcSEcCtD
Gemcitabine—Dermatitis—Captopril—systemic scleroderma	6.88e-05	0.000711	CcSEcCtD
Gemcitabine—Somnolence—Lisinopril—systemic scleroderma	6.87e-05	0.000711	CcSEcCtD
Gemcitabine—Headache—Captopril—systemic scleroderma	6.84e-05	0.000707	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—systemic scleroderma	6.79e-05	0.0378	CbGdCrCtD
Gemcitabine—Body temperature increased—Mycophenolic acid—systemic scleroderma	6.78e-05	0.000702	CcSEcCtD
Gemcitabine—Oedema—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.000701	CcSEcCtD
Gemcitabine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.000701	CcSEcCtD
Gemcitabine—Infection—Mycophenolate mofetil—systemic scleroderma	6.73e-05	0.000696	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisone—systemic scleroderma	6.72e-05	0.0374	CbGdCrCtD
Gemcitabine—Decreased appetite—Lisinopril—systemic scleroderma	6.72e-05	0.000695	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	6.67e-05	0.00069	CcSEcCtD
Gemcitabine—Fatigue—Lisinopril—systemic scleroderma	6.66e-05	0.000689	CcSEcCtD
Gemcitabine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000687	CcSEcCtD
Gemcitabine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	6.63e-05	0.000686	CcSEcCtD
Gemcitabine—Pain—Lisinopril—systemic scleroderma	6.61e-05	0.000684	CcSEcCtD
Gemcitabine—Constipation—Lisinopril—systemic scleroderma	6.61e-05	0.000684	CcSEcCtD
Gemcitabine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.00068	CcSEcCtD
Gemcitabine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.55e-05	0.000677	CcSEcCtD
Gemcitabine—Diarrhoea—Azathioprine—systemic scleroderma	6.52e-05	0.000674	CcSEcCtD
Gemcitabine—Haemoglobin—Prednisone—systemic scleroderma	6.49e-05	0.000672	CcSEcCtD
Gemcitabine—Nausea—Captopril—systemic scleroderma	6.48e-05	0.000671	CcSEcCtD
Gemcitabine—Haemorrhage—Prednisone—systemic scleroderma	6.46e-05	0.000668	CcSEcCtD
Gemcitabine—Anorexia—Mycophenolate mofetil—systemic scleroderma	6.46e-05	0.000668	CcSEcCtD
Gemcitabine—Asthenia—Leflunomide—systemic scleroderma	6.45e-05	0.000668	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—systemic scleroderma	6.41e-05	0.000663	CcSEcCtD
Gemcitabine—Feeling abnormal—Lisinopril—systemic scleroderma	6.37e-05	0.000659	CcSEcCtD
Gemcitabine—Pruritus—Leflunomide—systemic scleroderma	6.36e-05	0.000658	CcSEcCtD
Gemcitabine—Connective tissue disorder—Prednisone—systemic scleroderma	6.35e-05	0.000657	CcSEcCtD
Gemcitabine—Hypotension—Mycophenolate mofetil—systemic scleroderma	6.33e-05	0.000655	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—systemic scleroderma	6.31e-05	0.000653	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisone—systemic scleroderma	6.2e-05	0.0345	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.000638	CcSEcCtD
Gemcitabine—Asthenia—Mycophenolic acid—systemic scleroderma	6.16e-05	0.000637	CcSEcCtD
Gemcitabine—Diarrhoea—Leflunomide—systemic scleroderma	6.15e-05	0.000637	CcSEcCtD
Gemcitabine—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.13e-05	0.000634	CcSEcCtD
Gemcitabine—Body temperature increased—Lisinopril—systemic scleroderma	6.11e-05	0.000632	CcSEcCtD
Gemcitabine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.000629	CcSEcCtD
Gemcitabine—Pruritus—Mycophenolic acid—systemic scleroderma	6.07e-05	0.000628	CcSEcCtD
Gemcitabine—Vomiting—Azathioprine—systemic scleroderma	6.06e-05	0.000626	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—systemic scleroderma	6.05e-05	0.000626	CcSEcCtD
Gemcitabine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.04e-05	0.000625	CcSEcCtD
Gemcitabine—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.02e-05	0.000623	CcSEcCtD
Gemcitabine—Rash—Azathioprine—systemic scleroderma	6.01e-05	0.000621	CcSEcCtD
Gemcitabine—Dermatitis—Azathioprine—systemic scleroderma	6e-05	0.000621	CcSEcCtD
Gemcitabine—Headache—Azathioprine—systemic scleroderma	5.97e-05	0.000617	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	5.96e-05	0.000617	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—systemic scleroderma	5.91e-05	0.000612	CcSEcCtD
Gemcitabine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	5.89e-05	0.000609	CcSEcCtD
Gemcitabine—Diarrhoea—Mycophenolic acid—systemic scleroderma	5.87e-05	0.000607	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—systemic scleroderma	5.86e-05	0.000607	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—systemic scleroderma	5.86e-05	0.000606	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	5.85e-05	0.000605	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—systemic scleroderma	5.84e-05	0.000604	CcSEcCtD
Gemcitabine—Constipation—Mycophenolate mofetil—systemic scleroderma	5.79e-05	0.000599	CcSEcCtD
Gemcitabine—Pain—Mycophenolate mofetil—systemic scleroderma	5.79e-05	0.000599	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—systemic scleroderma	5.77e-05	0.000597	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—systemic scleroderma	5.77e-05	0.000597	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—systemic scleroderma	5.74e-05	0.000593	CcSEcCtD
Gemcitabine—Vomiting—Leflunomide—systemic scleroderma	5.72e-05	0.000592	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—systemic scleroderma	5.71e-05	0.000591	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—systemic scleroderma	5.69e-05	0.000588	CcSEcCtD
Gemcitabine—Rash—Leflunomide—systemic scleroderma	5.67e-05	0.000587	CcSEcCtD
Gemcitabine—Dermatitis—Leflunomide—systemic scleroderma	5.67e-05	0.000586	CcSEcCtD
Gemcitabine—Nausea—Azathioprine—systemic scleroderma	5.66e-05	0.000585	CcSEcCtD
Gemcitabine—Headache—Leflunomide—systemic scleroderma	5.64e-05	0.000583	CcSEcCtD
Gemcitabine—Erythema—Prednisone—systemic scleroderma	5.62e-05	0.000582	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—systemic scleroderma	5.61e-05	0.000581	CcSEcCtD
Gemcitabine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.58e-05	0.000577	CcSEcCtD
Gemcitabine—Asthenia—Lisinopril—systemic scleroderma	5.55e-05	0.000574	CcSEcCtD
Gemcitabine—Pruritus—Lisinopril—systemic scleroderma	5.47e-05	0.000566	CcSEcCtD
Gemcitabine—Vomiting—Mycophenolic acid—systemic scleroderma	5.46e-05	0.000564	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisone—systemic scleroderma	5.43e-05	0.0302	CbGdCrCtD
Gemcitabine—Haemoglobin—Methotrexate—systemic scleroderma	5.43e-05	0.000561	CcSEcCtD
Gemcitabine—Rash—Mycophenolic acid—systemic scleroderma	5.41e-05	0.00056	CcSEcCtD
Gemcitabine—Dermatitis—Mycophenolic acid—systemic scleroderma	5.41e-05	0.000559	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—systemic scleroderma	5.4e-05	0.000559	CcSEcCtD
Gemcitabine—Headache—Mycophenolic acid—systemic scleroderma	5.38e-05	0.000556	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—systemic scleroderma	5.36e-05	0.000554	CcSEcCtD
Gemcitabine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	5.35e-05	0.000554	CcSEcCtD
Gemcitabine—Nausea—Leflunomide—systemic scleroderma	5.34e-05	0.000553	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—systemic scleroderma	5.33e-05	0.000552	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—systemic scleroderma	5.29e-05	0.000548	CcSEcCtD
Gemcitabine—Diarrhoea—Lisinopril—systemic scleroderma	5.29e-05	0.000547	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—systemic scleroderma	5.22e-05	0.00054	CcSEcCtD
Gemcitabine—TYMS—Danazol—Prednisone—systemic scleroderma	5.21e-05	0.0289	CbGdCrCtD
Gemcitabine—Anaemia—Prednisone—systemic scleroderma	5.2e-05	0.000538	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—systemic scleroderma	5.11e-05	0.000528	CcSEcCtD
Gemcitabine—Nausea—Mycophenolic acid—systemic scleroderma	5.1e-05	0.000527	CcSEcCtD
Gemcitabine—Malaise—Prednisone—systemic scleroderma	5.07e-05	0.000525	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—systemic scleroderma	5.01e-05	0.000518	CcSEcCtD
Gemcitabine—Vomiting—Lisinopril—systemic scleroderma	4.91e-05	0.000508	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—systemic scleroderma	4.9e-05	0.000507	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—systemic scleroderma	4.88e-05	0.000505	CcSEcCtD
Gemcitabine—Rash—Lisinopril—systemic scleroderma	4.87e-05	0.000504	CcSEcCtD
Gemcitabine—Dermatitis—Lisinopril—systemic scleroderma	4.87e-05	0.000504	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—systemic scleroderma	4.87e-05	0.000503	CcSEcCtD
Gemcitabine—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.86e-05	0.000503	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—systemic scleroderma	4.86e-05	0.000502	CcSEcCtD
Gemcitabine—Chills—Methotrexate—systemic scleroderma	4.85e-05	0.000501	CcSEcCtD
Gemcitabine—Headache—Lisinopril—systemic scleroderma	4.84e-05	0.000501	CcSEcCtD
Gemcitabine—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.79e-05	0.000496	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—systemic scleroderma	4.79e-05	0.000495	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—systemic scleroderma	4.79e-05	0.000495	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—systemic scleroderma	4.77e-05	0.000494	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	4.76e-05	0.000492	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—systemic scleroderma	4.73e-05	0.000489	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—systemic scleroderma	4.7e-05	0.000486	CcSEcCtD
Gemcitabine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.63e-05	0.000479	CcSEcCtD
Gemcitabine—Nausea—Lisinopril—systemic scleroderma	4.59e-05	0.000475	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—systemic scleroderma	4.59e-05	0.000475	CcSEcCtD
Gemcitabine—Oedema—Prednisone—systemic scleroderma	4.59e-05	0.000475	CcSEcCtD
Gemcitabine—Infection—Prednisone—systemic scleroderma	4.56e-05	0.000472	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—systemic scleroderma	4.55e-05	0.00047	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—systemic scleroderma	4.5e-05	0.000466	CcSEcCtD
Gemcitabine—Skin disorder—Prednisone—systemic scleroderma	4.46e-05	0.000461	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—systemic scleroderma	4.44e-05	0.000459	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—systemic scleroderma	4.38e-05	0.000453	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—systemic scleroderma	4.36e-05	0.000451	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—systemic scleroderma	4.34e-05	0.000449	CcSEcCtD
Gemcitabine—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.31e-05	0.000445	CcSEcCtD
Gemcitabine—Rash—Mycophenolate mofetil—systemic scleroderma	4.27e-05	0.000442	CcSEcCtD
Gemcitabine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.27e-05	0.000441	CcSEcCtD
Gemcitabine—Headache—Mycophenolate mofetil—systemic scleroderma	4.24e-05	0.000439	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—systemic scleroderma	4.24e-05	0.000439	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—systemic scleroderma	4.21e-05	0.000435	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.18e-05	0.000433	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—systemic scleroderma	4.15e-05	0.000429	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—systemic scleroderma	4.12e-05	0.000426	CcSEcCtD
Gemcitabine—Cough—Methotrexate—systemic scleroderma	4.1e-05	0.000424	CcSEcCtD
Gemcitabine—Nausea—Mycophenolate mofetil—systemic scleroderma	4.02e-05	0.000416	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—systemic scleroderma	4e-05	0.000414	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—systemic scleroderma	4e-05	0.000414	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—systemic scleroderma	4e-05	0.000414	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—systemic scleroderma	3.99e-05	0.000413	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	3.97e-05	0.000411	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—systemic scleroderma	3.96e-05	0.000409	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—systemic scleroderma	3.95e-05	0.000409	CcSEcCtD
Gemcitabine—Constipation—Prednisone—systemic scleroderma	3.93e-05	0.000406	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—systemic scleroderma	3.84e-05	0.000397	CcSEcCtD
Gemcitabine—Infection—Methotrexate—systemic scleroderma	3.81e-05	0.000394	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisone—systemic scleroderma	3.78e-05	0.000391	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—systemic scleroderma	3.76e-05	0.000389	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—systemic scleroderma	3.76e-05	0.000389	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—systemic scleroderma	3.73e-05	0.000385	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—systemic scleroderma	3.71e-05	0.000384	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—systemic scleroderma	3.66e-05	0.000378	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—systemic scleroderma	3.63e-05	0.000375	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—systemic scleroderma	3.58e-05	0.000371	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.5e-05	0.000362	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—systemic scleroderma	3.47e-05	0.000359	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—systemic scleroderma	3.44e-05	0.000356	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—systemic scleroderma	3.42e-05	0.000354	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—systemic scleroderma	3.41e-05	0.000353	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—systemic scleroderma	3.33e-05	0.000345	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.31e-05	0.000343	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—systemic scleroderma	3.31e-05	0.000342	CcSEcCtD
Gemcitabine—Asthenia—Prednisone—systemic scleroderma	3.29e-05	0.000341	CcSEcCtD
Gemcitabine—Pain—Methotrexate—systemic scleroderma	3.28e-05	0.000339	CcSEcCtD
Gemcitabine—Pruritus—Prednisone—systemic scleroderma	3.25e-05	0.000336	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—systemic scleroderma	3.16e-05	0.000327	CcSEcCtD
Gemcitabine—Diarrhoea—Prednisone—systemic scleroderma	3.14e-05	0.000325	CcSEcCtD
Gemcitabine—Body temperature increased—Methotrexate—systemic scleroderma	3.03e-05	0.000314	CcSEcCtD
Gemcitabine—Vomiting—Prednisone—systemic scleroderma	2.92e-05	0.000302	CcSEcCtD
Gemcitabine—Rash—Prednisone—systemic scleroderma	2.89e-05	0.000299	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—systemic scleroderma	2.89e-05	0.000299	CcSEcCtD
Gemcitabine—Headache—Prednisone—systemic scleroderma	2.88e-05	0.000297	CcSEcCtD
Gemcitabine—Asthenia—Methotrexate—systemic scleroderma	2.75e-05	0.000285	CcSEcCtD
Gemcitabine—Nausea—Prednisone—systemic scleroderma	2.73e-05	0.000282	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—systemic scleroderma	2.71e-05	0.000281	CcSEcCtD
Gemcitabine—Diarrhoea—Methotrexate—systemic scleroderma	2.62e-05	0.000272	CcSEcCtD
Gemcitabine—Vomiting—Methotrexate—systemic scleroderma	2.44e-05	0.000252	CcSEcCtD
Gemcitabine—Rash—Methotrexate—systemic scleroderma	2.42e-05	0.00025	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—systemic scleroderma	2.42e-05	0.00025	CcSEcCtD
Gemcitabine—Headache—Methotrexate—systemic scleroderma	2.4e-05	0.000249	CcSEcCtD
Gemcitabine—Nausea—Methotrexate—systemic scleroderma	2.28e-05	0.000236	CcSEcCtD
